Clinical Trials Browser

Prostatic Hyperplasia, Prostatic Neoplasms, Lower Urinary Tract Symptoms

NCT05739071 2025-09-11

JING SI HERBAL TEA and Urinary Tract Symptoms in Bladder Cancer

Phase NA Enrolling by invitation

100 enrolled

Genitourinary

Urinary Bladder Neoplasms, Lower Urinary Tract Symptoms

NCT03802851 2025-08-27

HOLEP-RTPC

Phase NA Recruiting

30 enrolled

Genitourinary

Prostatic Neoplasms, Lower Urinary Tract Symptoms

NCT05415696 2024-08-09

Prostatic Artery Embolization for the Treatment of Lower Urinary Tract Symptoms in Prostate Cancer Patients Undergoing Radiation Therapy

Phase NA Withdrawn

Genitourinary

Prostatic Neoplasms, Lower Urinary Tract Symptoms

NCT00866554 2023-06-02

Efficacy and Toxicity of Bicalutamide and Dutasteride vs. Standard Care for Prostate Cytoreduction for Brachytherapy

Phase 2 Completed

60 enrolled

Genitourinary

Erectile Dysfunction, Prostatic Neoplasms, Lower Urinary Tract Symptoms

NCT05851521 2023-05-09

HERMES

Phase NA Unknown

120 enrolled

Genitourinary

Prostatic Hyperplasia, Prostatic Neoplasms, Urinary Retention, Lower Urinary Tract Symptoms

NCT03549650 2022-03-04

Prevention and Management of Intravesical BCG-related Lower Urinary Tract Symptoms

Phase 2 Terminated

3 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Lower Urinary Tract Symptoms

NCT04190641 2021-10-14

Single-use Cystoscope System for Direct Visualization of the Urethra and Bladder

Phase NA Completed

4 enrolled

Genitourinary

Urinary Bladder Neoplasms, Lower Urinary Tract Symptoms

NCT03831321 2019-02-05

The Effect of Preemptive Analgesia On The Comfort Of Patient and Doctor, in Cystoscopy

Phase 4 Unknown

144 enrolled

Genitourinary

Urinary Bladder Neoplasms, Hematuria, Pain, Prostatic Hyperplasia, Lower Urinary Tract Symptoms

NCT01678313 2014-07-15

Cyclooxygenase-2 (COX-2) Inhibitor Reduces Serum Prostatic Specific Antigen (PSA) Levels

Phase 2 Completed

140 enrolled 10 charts

Genitourinary

Prostatic Hyperplasia, Lower Urinary Tract Symptoms

NCT00681148 2013-11-21

Botulinum Toxin Injection With Prostate Brachytherapy

Phase 2 Withdrawn

Genitourinary

Prostatic Neoplasms, Lower Urinary Tract Symptoms

NCT01939756 2013-09-11

Baobab

Phase 1/2 Completed

50 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Lower Urinary Tract Symptoms

Clinical Trials

PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs

JING SI HERBAL TEA and Urinary Tract Symptoms in Bladder Cancer

HOLEP-RTPC

Prostatic Artery Embolization for the Treatment of Lower Urinary Tract Symptoms in Prostate Cancer Patients Undergoing Radiation Therapy

Efficacy and Toxicity of Bicalutamide and Dutasteride vs. Standard Care for Prostate Cytoreduction for Brachytherapy

HERMES

Prevention and Management of Intravesical BCG-related Lower Urinary Tract Symptoms

Single-use Cystoscope System for Direct Visualization of the Urethra and Bladder

The Effect of Preemptive Analgesia On The Comfort Of Patient and Doctor, in Cystoscopy

Cyclooxygenase-2 (COX-2) Inhibitor Reduces Serum Prostatic Specific Antigen (PSA) Levels

Botulinum Toxin Injection With Prostate Brachytherapy

Baobab